Collaborative Community Program Improves Asthma Care – Internal Medicine News Digital Network


Internal Medicine News Digital Network

Collaborative Community Program Improves Asthma Care
Internal Medicine News Digital Network
SAN FRANCISCO – A collaborative, community-based program to improve care for publicly insured children has reduced emergency department visits, hospitalizations, and costs, thanks in large part to a strong focus on asthma care. Dr. Tom Peterson and his

and more »

View full post on asthma – Google News

Researchers Claim LIGHT May Provide New Hope for Future Asthma Therapies – Genetic Engineering News

Researchers Claim LIGHT May Provide New Hope for Future Asthma Therapies
Genetic Engineering News
Researchers claim the TNF protein family member LIGHT may represent a new target for halting the process of airway remodeling that leads to decreased lung function in asthma patients. A team headed by scientists at La Jolla Institute for Allergy and

and more »

View full post on asthma – Google News

New therapeutic target for asthma, other lung disorders identified – Daily News & Analysis

New therapeutic target for asthma, other lung disorders identified
Daily News & Analysis
A researcher has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease (COPD)
LIGHT May Provide New Hope for Future Asthma Therapies, Researchers ClaimGenetic Engineering News
La Jolla Institute identifies new therapeutic target for asthma, COPD and ScienceBlog.com (blog)

all 13 news articles »

View full post on asthma – Google News

LIGHT May Provide New Hope for Future Asthma Therapies, Researchers Claim – Genetic Engineering News

LIGHT May Provide New Hope for Future Asthma Therapies, Researchers Claim
Genetic Engineering News
Researchers claim the TNF protein family member LIGHT may represent a new target for halting the process of airway remodelling that leads to decreased lung function in asthma patients. A team headed by scientists at La Jolla Institute for Allergy and
La Jolla Institute identifies new therapeutic target for asthma, COPD and EurekAlert (press release)

all 11 news articles »

View full post on asthma – Google News

New Guidelines On Managing Childhood Asthma Released

Children aged five and under – particularly those with intermittent viral-induced wheezing – should be treated with oral corticosteroids for asthma only if their wheeze is severe enough to require hospital admission, according to new guidelines.

The Thoracic Society of Australia and New Zealand (TSANZ) updated its position statement on corticosteroid use in childhood asthma after reviewing recently published clinical research.

The understanding of childhood asthma and recognition of the need for separate management guidelines for children aged five and under has increased since the TSANZ published its previous position statement in 2002, Professor Peter Van Asperen, Head of the Department of Respiratory Medicine at The Children’s Hospital at Westmead said in an editorial published in the latest Medical Journal of Australia.

“If control is not achieved using initial preventer therapy, it is important to review the diagnosis of asthma – particularly in children aged five years or younger – as many children with recurrent cough are mislabelled as having asthma,” Prof Van Asperen said.

“Oral corticosteroids improve outcomes in children presenting to hospital with acute asthma, but the efficacy of oral corticosteroids for children aged five years or younger with acute, mild-moderate, viral-induced wheezing has been questioned.

“In children aged five years or younger (particularly those with intermittent, viral-induced wheezing) the use of oral corticosteroids should be limited to those with severe wheeze who require hospital admission.”

The revised position statement also provides updated recommendations on the roles of inhaled corticosteroids, leukotriene receptor antagonists and combination medications in childhood asthma management. It highlights the role of leukotriene receptor antagonists as an alternative to long-acting beta-agonists as add on therapy in children not adequately controlled on inhaled corticosteroids and also recommends that long-acting beta-agonists not be used in children aged five years or younger.

Childhood eczema and hay fever leads to adult allergic asthma – Eureka! Science News


TopNews Arab Emirates

Childhood eczema and hay fever leads to adult allergic asthma
Eureka! Science News
Children who have eczema, particularly when occurring with hay fever, are nine times more likely to develop allergic asthma in their 40s, a new study reveals. The study was conducted by the University of Melbourne, the Murdoch Childrens Research
Childhood eczema linked to adult asthmaHerald Sun
Childhood eczema link to adult asthmaIce Gems
Childhood Eczema Along with Hay Fever Can Lead to Adult AsthmaTopNews Arab Emirates
FiveAA
all 12 news articles »

View full post on asthma – Google News

EPA Seeking Comments In Tulsa On Proposed Clean Air Plan – News On 6

EPA Seeking Comments In Tulsa On Proposed Clean Air Plan
News On 6
The EPA says exposure to sulfur dioxide can cause respiratory problems like increased asthma and aggravate existing heart disease. Thursday's meeting will be held at the Tulsa Tech, Riverside Campus in the Auditorium of the Alliance Conference Center
EPA says OK needs to clean upKFOR
Oklahoma residents air views on EPA planNewsOK.com
High sulfur dioxide emissions could lead to stronger restrictionsStarNewsOnline.com

all 8 news articles »

View full post on asthma – Google News